Search research articles
Contact Us
Filters
Showing results (141-150 of 538) with videos related to
Page
of 54
Sort By:
Nuclear Medicine Communications
|
February 1, 2011
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies
Trond Velde Bogsrud, Ian D Hay, Dimitrios Karantanis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 21, 2018
White Matter Reference Region in PET Studies of <sup>11</sup>C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition
Val J Lowe, Emily S Lundt, Matthew L Senjem, et al.
The Clinical Neuropsychologist
|
October 12, 2016
[Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status
Mary M Machulda, Clint E Hagen, Heather J Wiste, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
|
September 21, 2024
Baseline multimodal imaging to predict longitudinal clinical decline in atypical Alzheimer's disease
Ryan P Coburn, Jonathan Graff-Radford, Mary M Machulda, et al.
RSC Pharmaceutics
|
March 16, 2026
Synthesis and preliminary evaluation of cardiac imaging with [<sup>68</sup>Ga]Ga-NOTA-CTP in normal and infarcted CD1 mice
Surendra Reddy Gundam, Manasa Kethamreddy, Andy González Rivera, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 1, 2017
Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
Prashanthi Vemuri, Val J Lowe, David S Knopman, et al.
Brain and Language
|
August 16, 2023
Acoustic Analysis and Neuroimaging Correlates of Diadochokinetic Rates in Mild-Moderate Primary Progressive Apraxia of Speech
Kennedy A Josephs, Joseph R Duffy, Peter R Martin, et al.
Journal of Neurology
|
August 24, 2022
Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles
Neha Atulkumar Singh, Jonathan Graff-Radford, Mary M Machulda, et al.
Journal of Neuro-Oncology
|
January 14, 2018
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas
Ryan S Youland, Deanna H Pafundi, Debra H Brinkmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 23, 2014
Preparation and preliminary evaluation of 63Zn-zinc citrate as a novel PET imaging biomarker for zinc
Timothy R DeGrado, Mukesh K Pandey, John F Byrne, et al.
Page
of 54
Search research articles
Search
Showing results (141-150 of 538) with videos related to
Sort By:
Page
of 54
Nuclear Medicine Communications
|
February 1, 2011
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies
Trond Velde Bogsrud, Ian D Hay, Dimitrios Karantanis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 21, 2018
White Matter Reference Region in PET Studies of <sup>11</sup>C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition
Val J Lowe, Emily S Lundt, Matthew L Senjem, et al.
The Clinical Neuropsychologist
|
October 12, 2016
[Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status
Mary M Machulda, Clint E Hagen, Heather J Wiste, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
|
September 21, 2024
Baseline multimodal imaging to predict longitudinal clinical decline in atypical Alzheimer's disease
Ryan P Coburn, Jonathan Graff-Radford, Mary M Machulda, et al.
RSC Pharmaceutics
|
March 16, 2026
Synthesis and preliminary evaluation of cardiac imaging with [<sup>68</sup>Ga]Ga-NOTA-CTP in normal and infarcted CD1 mice
Surendra Reddy Gundam, Manasa Kethamreddy, Andy González Rivera, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 1, 2017
Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
Prashanthi Vemuri, Val J Lowe, David S Knopman, et al.
Brain and Language
|
August 16, 2023
Acoustic Analysis and Neuroimaging Correlates of Diadochokinetic Rates in Mild-Moderate Primary Progressive Apraxia of Speech
Kennedy A Josephs, Joseph R Duffy, Peter R Martin, et al.
Journal of Neurology
|
August 24, 2022
Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles
Neha Atulkumar Singh, Jonathan Graff-Radford, Mary M Machulda, et al.
Journal of Neuro-Oncology
|
January 14, 2018
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas
Ryan S Youland, Deanna H Pafundi, Debra H Brinkmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 23, 2014
Preparation and preliminary evaluation of 63Zn-zinc citrate as a novel PET imaging biomarker for zinc
Timothy R DeGrado, Mukesh K Pandey, John F Byrne, et al.
Page
of 54